Skip to main content

Perez Daniel Antonio's Form 4 filing

Hinge Health, Inc. (HNGE) · filed May 8, 2026

Accession no.
0002063236-26-000010
Filed
May 8, 2026
Trade date
May 6-7, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $8.26M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Perez Daniel AntonioCIK 0002063236Director, Officer (CEO & Co-Founder), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 6, 2026Class A Common StockCConversionAcquired+104,544$0.00$0140,014Indirect
May 6, 2026Class A Common StockSSaleDisposed−104,544$55.09F2−$5,759,328.9635,470Indirect
May 7, 2026Class A Common StockCConversionAcquired+45,456$0.00$080,926Indirect
May 7, 2026Class A Common StockSSaleDisposed−45,456$55.05F3−$2,502,352.835,470Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 6, 2026Class A Common StockCConversionDisposed−104,544$0.00$0403,901Indirect
May 7, 2026Class A Common StockCConversionDisposed−45,426$0.00$0358,445Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents the weighted average sale price. The lowest price at which shares were sold was $55.00 and the highest price at which shares were sold was $55.60. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F3

Represents the weighted average sale price. The lowest price at which shares were sold was $55.00 and the highest price at which shares were sold was $55.16. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)